These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9735323)

  • 1. Mechanism of protein A-induced amelioration of toxicity of anti-AIDS drug, zidovudine.
    Subbulakshmi V; Ghosh AK; Das T; Ray PK
    Biochem Biophys Res Commun; 1998 Sep; 250(1):15-21. PubMed ID: 9735323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamins C and E prevent AZT-induced leukopenia and loss of cellularity in bone marrow. Studies in mice.
    García-de-la-Asunción J; Gómez-Cambronero LG; Del Olmo ML; Pallardó FV; Sastre J; Viña J
    Free Radic Res; 2007 Mar; 41(3):330-4. PubMed ID: 17364962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by protein A of apoptotic cell death caused by anti-AIDS drug zidovudine.
    Ghosh AK; Jana S; Das T; Sa G; Mandal N; Ray PK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):601-4. PubMed ID: 10529409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
    Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice.
    Prakash O; Teng S; Ali M; Zhu X; Coleman R; Dabdoub RA; Chambers R; Aw TY; Flores SC; Joshi BH
    Arch Biochem Biophys; 1997 Jul; 343(2):173-80. PubMed ID: 9224727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
    Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
    Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
    Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
    Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine.
    Woody MA; Welniak LA; Sun R; Tian ZG; Henry M; Richards S; Raziuddin A; Longo DL; Murphy WJ
    Exp Hematol; 1999 May; 27(5):811-6. PubMed ID: 10340396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice.
    Difalco MR; Dufresne L; Congote LF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):449-54. PubMed ID: 9454783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice.
    Desai VG; Lee T; Moland CL; Branham WS; Von Tungeln LS; Beland FA; Fuscoe JC
    Mitochondrion; 2009 Feb; 9(1):9-16. PubMed ID: 18824140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
    Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
    Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H
    Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
    Diwan BA; Riggs CW; Logsdon D; Haines DC; Olivero OA; Rice JM; Yuspa SH; Poirier MC; Anderson LM
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):82-99. PubMed ID: 10558926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity.
    Freund YR; Dabbs J; Creek MR; Phillips SJ; Tyson CA; MacGregor JT
    Toxicol Appl Pharmacol; 2002 May; 181(1):16-26. PubMed ID: 12030838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
    Gao WY; Johns DG; Tanaka M; Mitsuya H
    Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. South African government rejects AZT advice.
    Cherry M
    Nature; 2000 Feb; 403(6771):692. PubMed ID: 10693770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.